Literature DB >> 7689487

Glucose does not influence the insulin-like growth factor (JGF) binding to carrier proteins (IGFBPs): analysis of rat and human serum by western ligand blotting.

S Cianfarani1, V J Frost, M O Savage, J M Holly.   

Abstract

The insulin-like growth factors (IGFs) circulate bound to specific proteins (termed IGFBP-1 through IGFBP-6) that modulate IGF bioactivity in tissues. The aim of this study was to analyse the effects of glucose on IGF binding to IGFBPs in rat and human serum by means of western ligand blotting. Serum samples were incubated with increasing concentrations of glucose (0 to 50 mmol/l), and EDTA (25 mmol/l) was added to inhibit protease activity. To analyse the effect of glucose on protection of IGFBPs from protease activity, serum from pregnant women (reported to be very rich in proteolytic activity against IGFBPs) was added to rat serum previously incubated with glucose. Glucose did not affect the 125I-IGF binding to rat and human serum IGFBPs. The intensity of IGFBP-3 bands decreased considerably during the incubation. This appeared to be due to endogenous protease activity, since the decrease was blocked by addition of EDTA. The incubation of rat serum with pregnant human serum produced a marked attenuation of IGFBP-3 and disappearance of IGFBP-4 bands. In conclusion, our study shows that glucose does not influence the IGF binding to IGFBP-3 either in rat or in human serum, confirms the presence of endogenous proteolytic activity in normal non-pregnant serum, and demonstrates that glucose has no protective action against protease activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689487     DOI: 10.1007/bf01923954

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  10 in total

1.  Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity.

Authors:  L C Giudice; E M Farrell; H Pham; G Lamson; R G Rosenfeld
Journal:  J Clin Endocrinol Metab       Date:  1990-10       Impact factor: 5.958

2.  A simple assay for proteolysis of IGFBP-3.

Authors:  G Lamson; L C Giudice; R G Rosenfeld
Journal:  J Clin Endocrinol Metab       Date:  1991-06       Impact factor: 5.958

3.  Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies.

Authors:  P Hossenlopp; D Seurin; B Segovia-Quinson; S Hardouin; M Binoux
Journal:  Anal Biochem       Date:  1986-04       Impact factor: 3.365

4.  Protein glycation: its role in the changes induced by diabetes in the properties of the serum insulin-like growth factor-I binding proteins.

Authors:  A M Cortizo; J J Gagliardino
Journal:  J Endocrinol       Date:  1991-10       Impact factor: 4.286

5.  Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein.

Authors:  A M Suikkari; V A Koivisto; E M Rutanen; H Yki-Järvinen; S L Karonen; M Seppälä
Journal:  J Clin Endocrinol Metab       Date:  1988-02       Impact factor: 5.958

Review 6.  Somatomedin-binding proteins: what role do they play in the growth process?

Authors:  S Cianfarani; J M Holly
Journal:  Eur J Pediatr       Date:  1989-11       Impact factor: 3.183

7.  The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabetics.

Authors:  A M Taylor; D B Dunger; M A Preece; J M Holly; C P Smith; J A Wass; S Patel; V E Tate
Journal:  Clin Endocrinol (Oxf)       Date:  1990-02       Impact factor: 3.478

8.  The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness.

Authors:  S C Davies; J A Wass; R J Ross; A M Cotterill; C R Buchanan; V J Coulson; J M Holly
Journal:  J Endocrinol       Date:  1991-09       Impact factor: 4.286

9.  Nutrition and somatomedin. II. Serum somatomedin activity and cartilage growth activity in streptozotocin-diabetic rats.

Authors:  L S Phillips; H S Young
Journal:  Diabetes       Date:  1976-06       Impact factor: 9.461

10.  Serum fructosamine concentration as measure of blood glucose control in type I (insulin dependent) diabetes mellitus.

Authors:  J R Baker; P A Metcalf; I M Holdaway; R N Johnson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.